| 2386 Pilot Study: TGF- ß Expression in Normal, Dysplasia & Carcinoma | ||
|
L. SITES, K. MEYER, A. NAWSHAD, and N. NARAYANA, University of Nebraska, Lincoln, USA An etiological risk factor for Oral Squamous Cell Carcinoma (OSCC) is continuous exposure of oral epithelia to growth factors, leading to uncontrolled growth and tumor invasion. Transforming Growth Factor ß (TGF- ß) is over-expressed in many types of cancers and correlates to tumor invasion. Three isoforms of TGF-ß ligands (1, 2 and 3) often signal for diverse yet completely opposing cellular functions. To date, the reports are contradictory about which isoform of TGF- ß is expressed in OSCCs. Moreover, it is not clear at which stage of OSCC development TGF- ß begins to express, and its role in OSCC carcinogenesis remains to be determined. Objective: In the present study, we have demonstrated that TGF- ß was frequently expressed in OSCC and adjacent tissues. Methods: Using paraffin-embedded human tissues, we studied normal, dysplastic, and OSCC biopsies of oral tissues from the University of Nebraska College of Dentistry tissue bank. Results: Our results showed that while TGF- ß3 is expressed mostly in the basal and parabasal layers of the epithelial cells, TGF- ß1 is expressed in suprabasal and keratinized layers. There was no significant expression of TGF- ß2. A common function of TGF- ß2 is its expression in the epithelial cells that are undergoing fibroblastic/fibroblastoid transformation. The tissues samples used in this study were not undergoing transformation and therefore did not express TGF- ß2. Our findings are in accord with the roles of different isoforms of TGF- ß. Conclusion: Our study suggests that TGF- ß1 and TGF- ß3 play significant but separate roles in the progression of OSCC. This study was funded by the College of Dentistry Summer Research Fellowship 2005. | ||
| Seq #240 - Premalignant Oral Lesions and Oral Cancer 3:30 PM-4:45 PM, Friday, March 23, 2007 Ernest N. Morial Convention Center Exhibit Hall I2-J | ||
|
Back to the Oral Medicine & Pathology Program
| ||